SignatureFD’s PDL BioPharma, Inc. PDLI Stock Holding History

SignatureFD’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-352	Closed	-$1K	–	2851
2020 Q2	$1K	Sell	352 -315	-47%	-$996	﹤0.01%	2466
2020 Q1	$2K	Sell	667 -718	-52%	-$2.31K	﹤0.01%	2050
2019 Q4	$4K	Sell	1,385 -2,861	-67%	-$8.3K	﹤0.01%	1741
2019 Q3	$9K	Buy	4,246 +1,121	+36%	+$3K	﹤0.01%	1483
2019 Q2	$10K	Hold	3,125	–	–	﹤0.01%	1427
2019 Q1	$12K	Buy	3,125 +200	+7%	+$675	﹤0.01%	1370
2018 Q4	$8K	Hold	2,925	–	–	﹤0.01%	1438
2018 Q3	$8K	Buy	2,925 +1,540	+111%	+$3.78K	﹤0.01%	1454
2018 Q2	$3K	Buy	+1,385	New	+$3.87K	﹤0.01%	1696
2015 Q1	–	Sell	-23	Closed	–	–	1100
2014 Q4	$0	Hold	23	–	–	﹤0.01%	1001
2014 Q3	$0	Hold	23	–	–	﹤0.01%	992
2014 Q2	$0	Sell	23 -425	-95%	-$3.79K	﹤0.01%	1104
2014 Q1	$4K	Buy	448 +425	+1,848%	+$3.64K	﹤0.01%	569
2013 Q4	$0	Hold	23	–	–	﹤0.01%	865
2013 Q3	$0	Hold	23	–	–	﹤0.01%	844
2013 Q2	$0	Buy	+23	New	+$179	﹤0.01%	660

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SignatureFD's PDLI Position: Q3 2020 in Review

SignatureFD sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 352 shares — an estimated $1K sold.

SignatureFD first reported a position in PDLI in Q2 2013 and held it in 16 quarters. The position peaked at $12K in Q1 2019. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

SignatureFD reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
SignatureFD sold 352 PDL BioPharma, Inc. shares in Q3 2020, an estimated $1K.
SignatureFD first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 16 quarters.
SignatureFD's PDL BioPharma, Inc. position peaked at $12K in Q1 2019.
132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on SignatureFD's 13F filing for Q3 2020, filed 3 Nov 2020.